ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In the study reported here, we addressed the effects of O2 (0.1%) or glucose shortage separately, comparing K562 with KCL22 CML cells, aiming at the characterization of molecular mechanism driving BCR/Abl protein suppression.